Dr. Guy Young is here to break down the latest data out of the BioMarin gene therapy clinical trial. We get a new Let’s Talk segment featuring Josh Bragg AND Patrick reveals a big secret. Don’t miss it! Show Notes:
Presenting Sponsor: Takeda
Subscribe to BloodStream Podcast: Link
BioMarin plans return to FDA with updated data on hemophilia gene therapy (BioPharmaDive): Link
BioMarin's hemophilia A gene therapy hits goal in phase 3, teeing up FDA filing despite durability doubts (Fierce Biotech): Link
Connect with BloodStream Media:
BloodStreamMedia.com
BloodStream on Facebook
BloodStream on Twitter
